The original success of Sildenafil undeniably revolutionized the medication landscape, but betting here in companies primarily reliant on unbranded versions presents a complex picture. Although early profits were impressive, the end of patents and the emergence of less expensive alternatives have weakened market share. Consequently, a thorough eval